Munyaradzi Musvosvi

Statistics

Publications

Citations

1.4K

H-Index

Active since

2013

Affiliations

University of Cape Town(Current)

South African Tuberculosis Vaccine Initiative

South African Medical Research Council

Statens Serum Institut

Fred Hutch Cancer Center

Munyaradzi Musvosvi is an author at University of Cape Town specializing in immunology, infectious diseases, and mycobacterium tuberculosis infection.

ORCID

Publications per year

2013–2025

Publications

Antigen Availability Shapes T Cell Differentiation and Function during Tuberculosis

Albanus O. Moguche, Munyaradzi Musvosvi, Adam Penn‐Nicholson et al. · Cell Host & Microbe · 2017 · 188 citations · Full text

Life Sciences, Immunology, Infectious Diseases +10

Biomarker-guided tuberculosis preventive therapy (CORTIS): a randomised controlled trial

Thomas J. Scriba, Andrew Fioré-Gartland, Adam Penn‐Nicholson et al. · The Lancet Infectious Diseases · 2021 · 154 citations · Full text

Public Health, Community Health, Preventive Medicine +17

Safety and immunogenicity of the novel tuberculosis vaccine ID93 + GLA-SE in BCG-vaccinated healthy adults in South Africa: a randomised, double-blind, placebo-controlled phase 1 trial

Adam Penn‐Nicholson, Michèle Tameris, Erica Smit et al. · The Lancet Respiratory Medicine · 2018 · 149 citations

Veterinary Medicine, Immunology, Infectious Diseases +15

Live-attenuated Mycobacterium tuberculosis vaccine MTBVAC versus BCG in adults and neonates: a randomised controlled, double-blind dose-escalation trial

Michèle Tameris, Helen Mearns, Adam Penn‐Nicholson et al. · The Lancet Respiratory Medicine · 2019 · 137 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +12

T cell receptor repertoires associated with control and disease progression following Mycobacterium tuberculosis infection

Munyaradzi Musvosvi, Huang Huang, Chunlin Wang et al. · Nature Medicine · 2023 · 100 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

1–5 of 23